MedPath
HSA Approval

Apo-Warfarin 5mg Tablet

SIN13517P

Apo-Warfarin 5mg Tablet

Apo-Warfarin 5mg Tablet

August 12, 2008

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

B01AA03

warfarin

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

Apotex Inc.

Active Ingredients

Warfarin (as warfarin sodium 92% 5.59mg)

5 mg

Warfarin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Apo-Warfarin 5mg Tablet - HSA Approval | MedPath